Related Experiment Video
Updated: Jun 24, 2025

10:16
In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
8.1K
Löfgren Syndrome: A Case Report and Treatment Challenge
João Miguel Peixoto1, Diogo Leal1, Dilva Silva1
1Internal Medicine, Centro Hospitalar e Universitário de Coimbra, Coimbra, PRT.
Cureus
|June 3, 2024
Summary
Löfgren syndrome, a distinct form of sarcoidosis, presents with erythema nodosum, hilar lymphadenopathy, and joint pain. This case highlights a rare aggressive presentation requiring steroid therapy.
Area of Science:
- Immunology
- Rheumatology
- Pulmonology
Background:
- Sarcoidosis is a multisystemic inflammatory disease of unknown cause, typically diagnosed via biopsy due to nonspecific symptoms.
- Löfgren syndrome (LöS) is a specific clinical presentation of sarcoidosis characterized by erythema nodosum, bilateral hilar lymphadenopathy, and arthralgia/arthritis.
- LöS often affects young women and typically has a favorable prognosis, often resolving spontaneously or with NSAID treatment.
Observation:
- This article details a case study of Löfgren syndrome in a young woman.
- The patient presented with an unusually aggressive disease course.
- The aggressive nature of the LöS necessitated treatment beyond standard NSAIDs.
Findings:
- The classic triad of erythema nodosum, bilateral hilar lymphadenopathy, and arthralgia/arthritis allowed for a clinical diagnosis of LöS, bypassing the need for biopsy.
- Despite the generally favorable prognosis of LöS, this case demonstrated a more severe manifestation.
- Steroidal therapy was required to manage the patient's aggressive Löfgren syndrome.
Implications:
- This case underscores that while Löfgren syndrome is often benign, atypical aggressive presentations can occur.
- Clinicians should be aware of potential treatment challenges in severe LöS cases.
- Further research may elucidate factors contributing to aggressive sarcoidosis phenotypes like this LöS case.

